Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting
Ian R Outhwaite, Sukrit Singh, Benedict-Tilman Berger, Stefan Knapp, John D Chodera, Markus A Seeliger, Yongliang Yang · 2023
Read Death by a thousand cuts through kinase inhibitor combinations that maximize selectivity and enable rational multitargeting by Ian R Outhwaite, Sukrit Singh, Benedict-Tilman Berger, Stefan Knapp, John D Chodera, Markus A Seeliger, Yongliang Yang (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10769483.txt.
Description
Outhwaite and co-authors present a 2023 paper on mixing kinase drugs to hit targets more cleanly. Kinase blockers treat cancer and immune disease, but the target family looks so alike that drugs often hit extra kinases. That spillover muddies research and care. Instead of chasing one perfect drug, the team combines drugs whose side targets differ.
Their scoring method, called MMS, rates mixes by strong target coverage and weak off-target spill. It can also plan mixes that strike several targets at once. On published data, the best mixes beat the cleanest single drug. Lab and cell tests confirmed the predicted gains. The frame extends to other drug families, the authors say.
Catalog record
| CREATOR | Ian R Outhwaite, Sukrit Singh, Benedict-Tilman Berger, Stefan Knapp, John D Chodera, Markus A Seeliger, Yongliang Yang |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 129 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |